decanoic acid and glucagon

decanoic acid has been researched along with glucagon in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chapman, IM; Feinle-Bisset, C; Feltrin, KL; Horowitz, M; Little, TJ; Meyer, JH; Pilichiewicz, AN; Rades, T; Smout, AJ; Wishart, J	1
Hirose, M; Kawabata, Y; Mizumoto, T; Onoue, S; Yamada, S; Yamamoto, K	1

Trials

1 trial(s) available for decanoic acid and glucagon

Article	Year
Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. American journal of physiology. Regulatory, integrative and comparative physiology, 2004, Volume: 287, Issue:3 Topics: Adult; Appetite; Cholecystokinin; Decanoic Acids; Double-Blind Method; Duodenum; Energy Intake; Fatty Acids; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Hormones; Humans; Infusions, Parenteral; Lauric Acids; Male; Manometry; Middle Aged; Peptide Fragments; Pilot Projects; Pressure; Protein Precursors; Pyloric Antrum; Pylorus; Sensation	2004

Article

Year

Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length.

American journal of physiology. Regulatory, integrative and comparative physiology, 2004, Volume: 287, Issue:3

Topics: Adult; Appetite; Cholecystokinin; Decanoic Acids; Double-Blind Method; Duodenum; Energy Intake; Fatty Acids; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Hormones; Humans; Infusions, Parenteral; Lauric Acids; Male; Manometry; Middle Aged; Peptide Fragments; Pilot Projects; Pressure; Protein Precursors; Pyloric Antrum; Pylorus; Sensation

2004

Other Studies

1 other study(ies) available for decanoic acid and glucagon

Article	Year
Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery. International journal of pharmaceutics, 2009, Dec-01, Volume: 382, Issue:1-2 Topics: Administration, Inhalation; Animals; Biological Transport; Blood Glucose; Cell Line; Chemistry, Pharmaceutical; Citric Acid; Decanoic Acids; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Glucagon; Humans; Hypoglycemic Agents; L-Lactate Dehydrogenase; Lasers; Male; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Powders; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors	2009

Article

Year

Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.

International journal of pharmaceutics, 2009, Dec-01, Volume: 382, Issue:1-2

Topics: Administration, Inhalation; Animals; Biological Transport; Blood Glucose; Cell Line; Chemistry, Pharmaceutical; Citric Acid; Decanoic Acids; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Glucagon; Humans; Hypoglycemic Agents; L-Lactate Dehydrogenase; Lasers; Male; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Powders; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors

2009